PenderFund Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

PenderFund Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-22,570	Closed	-$300K	–	141
2023 Q4	$300K	Buy	+22,570	New	+$102K	0.1%	71

PenderFund Capital Management's GRCL Position: Q1 2024 in Review

PenderFund Capital Management sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 22,570 shares — an estimated $300K sold.

PenderFund Capital Management first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $300K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

PenderFund Capital Management reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
PenderFund Capital Management sold 22,570 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $300K.
PenderFund Capital Management first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
PenderFund Capital Management's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $300K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on PenderFund Capital Management's 13F filing for Q1 2024, filed 15 May 2024.